慧智微(688512) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥136,864,395.13, representing a year-on-year increase of 30.63% compared to ¥104,771,108.87 in the same period last year[4] - The net profit attributable to shareholders was ¥3,567,106.59, a significant turnaround from a loss of ¥81,136,545.62 in the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥60,674,498.60, an improvement from -¥93,065,462.97 year-on-year[4] - The basic and diluted earnings per share were both ¥0.01, a recovery from -¥0.18 in the same period last year[4] - Total revenue for Q1 2025 reached ¥136,864,395.13, a 30.7% increase from ¥104,771,108.87 in Q1 2024[20] - Operating profit for Q1 2025 was ¥3,637,702.35, a significant recovery from a loss of ¥81,033,105.02 in Q1 2024[21] - Net profit for Q1 2025 was ¥3,567,106.59, compared to a net loss of ¥81,136,545.62 in Q1 2024[22] - Earnings per share for Q1 2025 was ¥0.01, a recovery from a loss of ¥0.18 per share in Q1 2024[22] Cash Flow and Liquidity - The net cash flow from operating activities was -¥55,223,289.45, which is less negative than -¥82,158,080.50 in the same period last year[4] - Cash flow from operating activities in Q1 2025 was ¥147,600,604.76, up from ¥108,404,462.62 in Q1 2024[23] - Net cash inflow from operating activities was CNY 158,582,808.12, compared to CNY 132,381,836.45 in the previous period, reflecting an increase of approximately 19.7%[24] - Total cash outflow from operating activities was CNY 213,806,097.57, slightly decreased from CNY 214,539,916.95, indicating a marginal improvement[24] - The total cash and cash equivalents at the end of the period stood at CNY 753,937,524.03, down from CNY 897,412,304.02, representing a decrease of approximately 16.0%[25] - The company reported a net cash decrease of CNY 76,371,359.81, compared to a much larger decrease of CNY 453,197,962.23 in the previous period, indicating improved cash management[25] Research and Development - Research and development (R&D) expenses totaled ¥45,630,814.75, a decrease of 30.76% from ¥65,903,742.87 in the previous year[5] - R&D expenses accounted for 33.34% of operating revenue, down by 29.56 percentage points from the previous year[5] - Research and development expenses decreased to ¥45,630,814.75 in Q1 2025 from ¥65,903,742.87 in Q1 2024, indicating a 30.8% reduction[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,173,167,180.80, a decrease of 1.74% from ¥2,211,677,058.74 at the end of the previous year[5] - Total liabilities decreased from ¥405,367,867.98 to ¥348,440,063.44, a reduction of about 14.0%[18] - The company's equity attributable to shareholders increased from ¥1,806,309,190.76 to ¥1,824,727,117.36, showing a growth of approximately 1.0%[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 14,983[11] - The largest shareholder, Li Yang, holds 34,781,200 shares, representing 7.55% of the total shares[11] - The total number of shares held by the top 10 shareholders accounts for a significant portion of the company's equity, with the largest institutional investor holding 26,028,448 shares, or 5.65%[12] Government Support and Market Strategy - The company confirmed government subsidies of ¥60,669,600.14, contributing positively to the financial results[6] - The company is focused on maintaining a stable financial position while exploring new market opportunities and potential expansions[15] - There are no significant changes in the operational status of the company during the reporting period that require investor attention[13]